reviewNature reviews. CancerJan 31, 2003Closed access

Inhibiting the p53–MDM2 interaction: an important target for cancer therapy

PCPatrick Chêne

Novartis (Switzerland)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

757
total citations
FWCI
19.12
Percentile
100%
References
78
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Mdm2
  • Suppressor
  • Cancer research
  • Apoptosis
  • Cancer
  • MDMX
  • Cell cycle checkpoint
  • Cancer cell
No related works found for this paper.